MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines.

Wafaa M RashedMohamed A KandeilMohamed O MahmoudDoha MaherSameera EzzatMohamed H Abdel-Rahman

Published in: Journal of cancer research and clinical oncology (2020)

MET RNA expression could be useful biomarker for tivantinib and crizotinib targeted therapy in HCC. The value of assessment of MET protein expression is limited.

Keyphrases

tyrosine kinase
poor prognosis
binding protein
long non coding rna
epidermal growth factor receptor
cancer therapy
single cell